Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases.
52W Range
3rdpctl
Volume
0.41×avg
Market Cap
49.48MUSD
P/E Ratio
-2.1TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Seres Therapeutics, Inc.
MCRBNASDAQ Global Select·USD·Closed
Seres Therapeutics, Inc.
MCRBNASDAQ·USD·Closed
$5.11
+3.23%
$5.11
+$0.16 (3.23%)
52W Range
3rdpctl
Volume
0.41×avg
Mkt Cap
49.48MUSD
P/E
-2.1TTM
Div Yield
–ann
MCRB: Seres Therapeutics, Inc. Stock Analysis | finqOS
